Emma Stanton

Emma Stanton is the Senior Vice President of Clinical Affairs and Head of Oxford Nanopore Diagnostics at Oxford Nanopore Technologies. She has held this position since 2020, contributing significantly to the company's focus on innovative diagnostic solutions.

Education and Background::

• Dr. Stanton has a background in clinical research and diagnostics, with educational credentials from Harvard Business School, which enhances her expertise in the field.

Professional Experience::

• Prior to her role at Oxford Nanopore Technologies, Emma Stanton has accumulated extensive experience in various leadership positions, demonstrating her capabilities in driving clinical strategies and operational excellence within the biotechnology sector.

Current Role::

• As Senior Vice President, she oversees the clinical development and implementation of diagnostic products that utilize Oxford Nanopore's unique sequencing technology, aiming to improve healthcare outcomes through accessible genomic information.

Stanton's leadership is pivotal in advancing the company's mission to democratize access to DNA sequencing and enhance the capabilities of diagnostic testing globally.